At the end of May and the beginning of June the International Congress
of Ophthalmology “White Nights” took place, its long history giving it a
status of the most significant ophthalmological event of St.
Petersburg. The Congress annually attracts considerable attention of the
medical community, and becomes the ground for discussions of the most
vital matters of ophthalmology.
More than 1,600 Russian and foreign doctors, experts, and
representatives of the pharmaceutical industry took part in the Congress
this year. A comprehensive academic and research program was prepared
for the specialists. The program was devoted to the latest achievements
of ophthalmology, modern diagnostic and treatment techniques for
ophthalmological diseases. Traditionally, the exhibition of products
manufactured by the leading Russian and foreign pharmaceutical companies
was offered to the participants.
The theoretical and practical symposium "Innovations in the Treatment
of Retinal Diseases" organized by GEROPHARM was chaired by Professor
Vladimir Vladimirovich Neroev, the Chief Neurologist of the Ministry of
Health and Social Development of the Russian Federation, Honored Doctor
of the RF, and the Director of the Helmholtz Moscow Research Institute.
Olga Ivanovna Sarygina, the Chief Researcher, Head of the retinal
pathology and optic nerve Division of the Helmholtz Moscow Research
Institute, presented the research results of the therapeutic
effectiveness and safety of Retinalamin for myopia treatment. It was
demonstrated that Retinalamin provides better acuity of vision, enhances
the functional activity of neurons in the inner nuclear layer of the
peripheral and central retina sections, and the activity of the
photoreceptors of the macular area. Apart from the foregoing, the drug
helps to increase retina photosensitivity, and reduce the average defect
level of the central threshold photosensitivity. No allergic reactions
and no undesirable effects were registered among the patients in the
course of drug administration.
Natalia Vladimirovna Morozova, Candidate of Medical Sciences, Deputy
Chief Doctor for clinical work of St. Petersburg City Diagnostic Center
No. 8, reported the clinical efficiency of Retinalamin for the
proliferative diabetic retinopathy after the laser-based treatment of
patients. In the course of the research Retinalamin was administered
with the convenient, high-efficiency, and minimally invasive method of
endonasal electrophoresis. The work continues the research series of St.
Petersburg authors under the guidance of the Professor Jury Sergeevich
Astakhov, Doctor of Medical Sciences, Chief Ophthalmologist of St.
Elvira Irekovna Saidasheva, Professor, Head of the Chair of Infant
Ophthalmology of St. Petersburg Academy of Postgraduate Studies,
reported on the urgency of ophtalmo-neuroprotection in infants
treatment, and submitted the data certifying Retinalamin efficiency in
retinopathy among low-birth-weight infants, and of Cortexin used for the
treatment of optic nerve atrophy of various genesis.
The report made by Venera Uzbekovna Galimova, Doctor of Medical
Sciences, Professor of the Chair of Ophthalmic and Plastic Surgery of
the Bashkir Medical University (Ufa city), Deputy Director of the FGU
(Federal State Institution) All-Russian Center of Ophthalmic and Plastic
Surgery of Roszdrav, was final in the symposium. In her report the
Professor informed the participants about the efficiency of an
integrated approach to the therapy of pigmentary retinopathy with the
use of Retinalamin, and Cortexin between surgical treatment stages.
The theoretical and practical program of the Congress aroused great interest to all the participants. The specialists got acquainted with the data of the most progressive research in the field of ophthalmology at the issue-related lectures and seminars.